Literature DB >> 19451717

Color discrimination performance in patients with Alzheimer's disease.

Giovanna Salamone1, Concetta Di Lorenzo, Serena Mosti, Federica Lupo, Luca Cravello, Katie Palmer, Massimo Musicco, Carlo Caltagirone.   

Abstract

BACKGROUND/AIMS: Visual deficits are frequent in Alzheimer's disease (AD), yet little is known about the nature of these disturbances. The aim of the present study was to investigate color discrimination in patients with AD to determine whether impairment of this visual function is a cognitive or perceptive/sensory disturbance.
METHODS: A cross-sectional clinical study was conducted in a specialized dementia unit on 20 patients with mild/moderate AD and 21 age-matched normal controls. Color discrimination was measured by the Farnsworth-Munsell 100 hue test. Cognitive functioning was measured with the Mini-Mental State Examination (MMSE) and a comprehensive battery of neuropsychological tests. The scores obtained on the color discrimination test were compared between AD patients and controls adjusting for global and domain-specific cognitive performance.
RESULTS: Color discrimination performance was inversely related to MMSE score. AD patients had a higher number of errors in color discrimination than controls (mean +/- SD total error score: 442.4 +/- 84.5 vs. 304.1 +/- 45.9). This trend persisted even after adjustment for MMSE score and cognitive performance on specific cognitive domains.
CONCLUSIONS: A specific reduction of color discrimination capacity is present in AD patients. This deficit does not solely depend upon cognitive impairment, and involvement of the primary visual cortex and/or retinal ganglionar cells may be contributory.

Entities:  

Mesh:

Year:  2009        PMID: 19451717     DOI: 10.1159/000218366

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  15 in total

1.  Incidence of dyschromatopsy in glaucoma.

Authors:  Laura Bayer; Jens Funk; Marc Töteberg-Harms
Journal:  Int Ophthalmol       Date:  2019-11-08       Impact factor: 2.031

Review 2.  A systematic survey of advances in retinal imaging modalities for Alzheimer's disease diagnosis.

Authors:  Richa Vij; Sakshi Arora
Journal:  Metab Brain Dis       Date:  2022-03-15       Impact factor: 3.655

3.  Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease.

Authors:  Elena Salobrar-Garcia; Rosa de Hoz; Blanca Rojas; Ana I Ramirez; Juan J Salazar; Raquel Yubero; Pedro Gil; Alberto Triviño; José M Ramirez
Journal:  J Ophthalmol       Date:  2015-05-27       Impact factor: 1.909

4.  Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis.

Authors:  Gianluca Coppola; Antonio Di Renzo; Lucia Ziccardi; Francesco Martelli; Antonello Fadda; Gianluca Manni; Piero Barboni; Francesco Pierelli; Alfredo A Sadun; Vincenzo Parisi
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

5.  Scene categorization in Alzheimer's disease: a saccadic choice task.

Authors:  Quentin Lenoble; Giovanna Bubbico; Sébastien Szaffarczyk; Florence Pasquier; Muriel Boucart
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-01-16

Review 6.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview.

Authors:  María Alejandra Cerquera-Jaramillo; Mauricio O Nava-Mesa; Rodrigo E González-Reyes; Carlos Tellez-Conti; Alejandra de-la-Torre
Journal:  Neural Plast       Date:  2018-10-14       Impact factor: 3.599

7.  Changes in visual function and retinal structure in the progression of Alzheimer's disease.

Authors:  Elena Salobrar-García; Rosa de Hoz; Ana I Ramírez; Inés López-Cuenca; Pilar Rojas; Ravi Vazirani; Carla Amarante; Raquel Yubero; Pedro Gil; María D Pinazo-Durán; Juan J Salazar; José M Ramírez
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

8.  The Retina in Alzheimer's Disease: Histomorphometric Analysis of an Ophthalmologic Biomarker.

Authors:  Samuel Asanad; Fred N Ross-Cisneros; Marco Nassisi; Ernesto Barron; Rustum Karanjia; Alfredo A Sadun
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-04-01       Impact factor: 4.799

Review 9.  Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression.

Authors:  Fatimah Zara Javaid; Jonathan Brenton; Li Guo; Maria F Cordeiro
Journal:  Front Neurol       Date:  2016-04-19       Impact factor: 4.003

10.  Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline.

Authors:  Samuel Asanad; Michele Fantini; William Sultan; Marco Nassisi; Christian M Felix; Jessica Wu; Rustum Karanjia; Fred N Ross-Cisneros; Abhay P Sagare; Berislav V Zlokovic; Helena C Chui; Janice M Pogoda; Xianghong Arakaki; Alfred N Fonteh; Alfredo A Sadun; Michael G Harrington
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.